DEA Role must be Clearly defined in Controlled Substance Rx via Telemedicine, Expert Cautions

The U.S. Drug Enforcement Administration has proposed draft guidance to establish a framework for prescribing controlled substances via telemedicine.The proposal introduces three types of special registrations. Telemedicine prescribing registration allows qualified practitioners to prescribe Schedule III-V controlled substances via telemedicine. Advanced telemedicine prescribing registration permits specialized practitioners, such as psychiatrists and hospice care physicians, to prescribe Schedule II-V controlled substances via telemedicine. And telemedicine platform registration enables online telemedicine platforms to dispense Schedule II-V controlled substances through registered practitioners.The guidance proposes allowing patients to receive a six-month supply of buprenorphine, used to treat opioid use disorder, through a telephone consultation with a provider. Subsequent prescriptions would require an in-person visit.